Kontigo Care Q4 2023: Strong MRR growth - Redeye

Redeye gives its initial take on Kontigo Care’s Q4 2023 report, which came in slightly softer than we anticipated. Lower activated expenses and a slightly softer topline account for the EBIT deviation. Notable highlights include an all-time high Monthly Recurring Revenue (MRR) and agreements now covering approximately 60% of municipalities in Sweden. We anticipate making only minor adjustments to our financial forecasts and valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/974141/kontigo-care-q4-2023-strong-mrr-growth?utm_source=finwire&utm_medium=RSS